CRG: New Alliance for European Excellence and Competitiveness in Life Sciences

CRG: New Alliance for European Excellence and Competitiveness in Life Sciences

News from CRG

On May 29, at the Centre for Genomic Regulation (CRG), in Barcelona, directors and staff from ten top European research institutes kicked off a new alliance, called EU-LIFE, that will promote European research. The mission of EU-LIFE is to foster excellence, share knowledge, and influence policies in life sciences. Partners in EU-LIFE are renowned research centres that operate with similar principles of excellence, external reviews, independence, competitiveness, and internationality. During difficult economic times and within a highly competitive international research landscape, they believe that they can join forces to better address complex questions, thereby contributing to pushing European science forward.

"Why are we often not able to attract top students from the US? Why do many of our junior talents leave to other continents and don’t return?", reflects Luis Serrano, director of the Centre for Genomic Regulation (CRG, Spain) and one of the co-founders of this initiative. “There are many excellent research institutes in Europe. By increasing our international visibility through EU-LIFE, we aim to raise awareness for European science. Instead of working independently, we want to coordinate our efforts to create added value for Europe. We envision, for example, to agree on common standards for Ph.D. and postdoctoral recruitment and training programmes, and to organize joint scientific events for young scientists."

Current partners of this association are the co-leaders CRG and VIB (Belgium), the Institut Curie (France), the Netherlands Cancer Institute (Netherlands), the Max Delbrück Center for Molecular Medicine; MDC, Berlin-Buch (Germany), Istituto Europeo di Oncologia (Italy), Instituto Gulbenkian de Ciência (Portugal), the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (Austria), CEITEC (Czech Republic), and the Institute for Molecular Medicine Finland (Finland).

More information:

CRG press release

Article in Science

EU-LIFE website